{
    "Trade/Device Name(s)": [
        "Sofia 2 Campylobacter FIA"
    ],
    "Submitter Information": "Quidel Corporation",
    "510(k) Number": "K211342",
    "Predicate Device Reference 510(k) Number(s)": [
        "K191456"
    ],
    "Regulatory Class": "Class I, reserved",
    "Product Code(s)": [
        "LQP",
        "KHO"
    ],
    "Summary Letter Date": "April 30, 2021",
    "Summary Letter Received Date": "May 3, 2021",
    "Submission Date": "November 22, 2021",
    "Regulation Number(s)": [
        "21 CFR 866.3110"
    ],
    "Regulation Name(s)": [
        "Campylobacter fetus Serological Reagents"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Campylobacter jejuni",
        "Campylobacter coli",
        "Campylobacter lari",
        "Campylobacter upsaliensis"
    ],
    "Specimen Type(s)": [
        "Human fecal specimens"
    ],
    "Specimen Container(s)": [
        "Specimen Tube with Specimen Solution",
        "Transport media (Cary Blair)",
        "Transport media (C&S)"
    ],
    "Instrument(s)/Platform(s)": [
        "Sofia 2"
    ],
    "Method(s)/Technology(ies)": [
        "Immunofluorescence"
    ],
    "Methodologies": [
        "Lateral-flow",
        "Qualitative antigen detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Test",
        "Cassette",
        "Reagent",
        "Control",
        "Instrument"
    ],
    "Document Summary": "FDA 510(k) summary for Sofia 2 Campylobacter FIA immunofluorescence assay to qualitatively detect Campylobacter antigens in human fecal specimens using the Sofia 2 instrument",
    "Indications for Use Summary": "Qualitative detection of Campylobacter-specific antigens (C. jejuni, C. coli, C. lari, C. upsaliensis) in human fecal specimens from patients with signs and symptoms of gastroenteritis, using preserved and unpreserved fecal samples, interpreted in conjunction with clinical findings and patient history",
    "fda_folder": "Microbiology"
}